Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm
Integra LifeSciences Holdings Corporation (IART)
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.integralife.com
Company Research
Source: Business Wire
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it has commenced an investigation into Integra LifeSciences Holdings Corp. (NASDAQ: IART) (“Integra”) on behalf of the company’s long-term shareholders.https://kaskelalaw.com/case/integra-lifesciences/Recently a securities fraud complaint was filed against Integra on behalf of investors who purchased shares of the company’s stock between March 11, 2019 and May 22, 2023 (the “Class Period”). According to the complaint, during the Class Period Integra and certain of the company’s senior executive officers issued a series of materially false and misleading statements to investors concerning the company’s business, operations and prospects.As detailed in the complaint, on October 9, 2018, the FDA began an inspection of the company’s Boston Facility, during which it observed that Integra’s quality systems and manufacturing conditions were “not in conformity with the current good manufacturing practice requirements of the Qua
Show less
Read more
Impact Snapshot
Event Time:
IART
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IART alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IART alerts
High impacting Integra LifeSciences Holdings Corporation news events
Weekly update
A roundup of the hottest topics
IART
News
- Minimally Invasive Spinal Devices Pipeline Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape [Yahoo! Finance]Yahoo! Finance
- Global Wound Filler Market Set for Steady Growth, projected to Reach USD 948.7 Million by 2034 with a 4.4% of CAGR | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure [Yahoo! Finance]Yahoo! Finance
- Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target raised by analysts at Citigroup Inc. from $16.00 to $22.00. They now have a "sell" rating on the stock.MarketBeat
- Integra LifeSciences Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]Yahoo! Finance
IART
Earnings
- 11/4/24 - Beat
IART
Sec Filings
- 11/12/24 - Form SC
- 11/12/24 - Form SC
- 11/4/24 - Form S-8
- IART's page on the SEC website